Correlation of PET-CT Studies With Serum Protein Analysis

This study has been completed.
Sponsor:
Information provided by:
Stanford University
ClinicalTrials.gov Identifier:
NCT00547742
First received: October 19, 2007
Last updated: July 16, 2010
Last verified: July 2010
  Purpose

To correlate serum proteomics patterns with PET/CT findings to improve cancer diagnosis, staging, prognosis, and therapy monitoring.


Condition Intervention
Carcinomas (Including Squamous Cell and Adenocarcinoma)
Procedure: PET/CT Scan
Procedure: phlebotomy

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Correlation of PET-CT Studies With Serum Protein Analysis

Further study details as provided by Stanford University:

Biospecimen Retention:   Samples Without DNA

blood


Estimated Enrollment: 1500
Study Start Date: July 2005
Study Completion Date: June 2009
Primary Completion Date: March 2009 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Patients having PET/CT scans

Criteria

Inclusion Criteria:1. Patients must have a PET/CT study performed at the time of blood collection.

2. Patients must understand and voluntarily sign an Informed Consent form after the contents have been fully explained to them.

Exclusion Criteria:1. Patients who are not eligible for a PET/CT study.

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00547742

Locations
United States, California
Stanford University School of Medicine
Stanford, California, United States, 94305
Sponsors and Collaborators
Stanford University
Investigators
Principal Investigator: Dr Andrew Quon Stanford University
  More Information

No publications provided

Responsible Party: Dr Andrew Quon, Stanford University School of Medicine
ClinicalTrials.gov Identifier: NCT00547742     History of Changes
Other Study ID Numbers: VAR0011, 96184, VAR0011
Study First Received: October 19, 2007
Last Updated: July 16, 2010
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Adenocarcinoma
Carcinoma
Neoplasms, Glandular and Epithelial
Neoplasms by Histologic Type
Neoplasms

ClinicalTrials.gov processed this record on April 17, 2014